FDA+ roundup: Spring regulatory agenda looks to finish off Cures implementation; GAO digs into medical countermeasures
The Biden administration released its Spring regulatory agenda, offering up plans on which proposed and final rulemakings will be coming down the pike in the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.